Myopia is a refractive disorder of the eye that is becoming increasingly prevalent throughout the world. In 2000, an estimated 22.9% of the world population had myopia. By 2010, that figure increased to 28.3% of the global population. Diagnosis is expected to increase to nearly 50% of the world’s population by 2050. This will have a diverse impact on the social, economic and health care systems globally.
It is vital for clinicians to be aware of the new approaches to reducing myopia progression in children as well as the relative risks of new therapies. Several therapeutic approaches are now showing efficacy in reducing myopia progression— with low-dose atropine eye drops appearing to be the most promising. It is well recognized that a childhood myopia diagnosis is associated with a higher degree of myopia in adult life.
This Focal Points module examines the increasing prevalence and clinical impact of myopia, and evaluates the safety and efficacy of emerging therapeutic modalities. Genetic and environmental contributing factors are also discussed.
Complete this module to:
- Recognize the associated signs and complications of myopia and pathologic myopia.
- Gain a deeper understanding of the rising prevalence of myopia globally and its impact on social, economic and health care systems.
- Summarize the etiology of myopia.
- Efficiently describe effective interventions available in the control of myopia in children.
Authors: Donald Tan, MD, FRCS, FRCOphth; Su Ann Tay, MD
Consultants: Seo Wei Leo, MD; David Anthony Mackey, MD, FRANZCO
Focal Points issues are practical, hands-on discussions of the clinical issues you face daily. Each issue delivers high-quality, trusted ophthalmic information written and reviewed by leading experts.
Subscribers receive 12 issues a year, plus access to the Focal Points digital archive.
To access this issue from your laptop or desktop computer, log in to www.aao.org/myonlineproducts with your Academy username and password.
To access this issue from your smartphone or tablet, use the free AAO eBooks app.
The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Ophthalmology designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.